Literature DB >> 22390184

Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.

Kirk W Sears1, Kenneth J Drobatz, Rebecka S Hess.   

Abstract

OBJECTIVES: To characterize the use of lispro insulin in dogs with diabetes ketoacidosis (DKA) and to compare the length of time required for resolution of hyperglycemia, ketosis, and acidosis, respectively, in dogs with DKA treated with lispro or with regular insulin.
DESIGN: Randomized prospective clinical trial performed between November 2006 and May 2009.
SETTING: University teaching hospital. ANIMALS: Client-owned dogs with naturally occurring DKA. Dogs with a blood glucose (BG) > 13.9 mmol/L (>250 mg/dL), blood pH between 7.0 and 7.35, and a blood beta-hydroxybutyrate (BOHB) concentration >2.0 mmol/L were eligible to be enrolled into the study and were randomly assigned to receive an IV continuous rate infusion (CRI) of either lispro or regular insulin.
INTERVENTIONS: Lispro or regular insulin was administered as an IV CRI at an initial dose of 0.09 U/kg/h. The dose was adjusted according to a previously published protocol.
MEASUREMENTS AND MAIN RESULTS: Twelve dogs were enrolled into the study. The time to biochemical resolution of DKA was defined as the time interval from when the IV CRI of insulin began until marked hyperglycemia (BG > 13.9 mmol/L [>250 mg/dL]), acidosis (venous pH < 7.35), and ketosis (BOHB concentration >2.0 mmol/L) resolved. The median time to biochemical resolution of DKA in dogs treated with lispro insulin was significantly shorter (26 h; range 26-50 h) than in dogs treated with regular insulin (61 h; range, 38-80 h, P = 0.02). Median admission blood glucose concentration of all 12 dogs (24 mmol/L [432 mg/dL; range, 17.8-38.9 mmol/L [321-700 mg/dL]) decreased significantly with fluid resuscitation and prior to insulin therapy (20.5 mmol/L [369 mg/dL; range, 14.5-33.3 mmol/L [261-600 mg/dL], P = 0.0085). No adverse effects were observed in association with IV lispro insulin administration.
CONCLUSIONS: Treatment of DKA in dogs with IV CRI lispro insulin is safe, and as effective as treatment with regular insulin. © Veterinary Emergency and Critical Care Society 2012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390184     DOI: 10.1111/j.1476-4431.2012.00719.x

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  5 in total

1.  Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

Authors:  Allison L O'Kell; Clive Wasserfall; Brian Catchpole; Lucy J Davison; Rebecka S Hess; Jake A Kushner; Mark A Atkinson
Journal:  Diabetes       Date:  2017-06       Impact factor: 9.461

2.  Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats.

Authors:  Jodie D Anderson; Danielle A Rondeau; Rebecka S Hess
Journal:  J Vet Intern Med       Date:  2019-05-27       Impact factor: 3.333

3.  Beta-hydroxybutyrate Concentrations in Dogs with Acute Pancreatitis and Without Diabetes Mellitus.

Authors:  F E Hurrell; K J Drobatz; R S Hess
Journal:  J Vet Intern Med       Date:  2016-04-13       Impact factor: 3.333

Review 4.  Update on insulin treatment for dogs and cats: insulin dosing pens and more.

Authors:  Ann Thompson; Patty Lathan; Linda Fleeman
Journal:  Vet Med (Auckl)       Date:  2015-04-15

5.  Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis.

Authors:  Eleonora Malerba; Federica Alessandrini; Giorgio Grossi; Massimo Giunti; Federico Fracassi
Journal:  Front Vet Sci       Date:  2020-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.